CSL312 Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis
A Randomized, Double-blind, Placebo-controlled, Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of CSL312 in Subjects with Idiopathic Pulmonary Fibrosis A Randomized, Double-blind, Placebo-controlled, Study to Investigate the Safety, Pharmacokinetics, a ...
Product Name: Factor XIIa antagonist monoclonal antibody Product Code: CSL312 Garadacimab INN or Proposed INN: FXIIa inhibitor monoclonal antibody Other descriptive name: Garadacimab Product Name: Factor XIIa antagonist monoclonal antibody Product Code: CSL312 Garadacimab INN or Propo ...
CSL Behring LLC
NULL
Authorised-recruitment may be ongoing or finished
Female: yes Male: yes
80
Phase 2
United States;Czechia;Spain;Ukraine;Lithuania;Austria;United Kingdom;Italy;Switzerland;France;Canada;Belgium;Poland;Denmark;Australia;Norway;Germany;Latvia;Netherlands;Sweden United States;Czechia;Spain;Ukraine;Lithuania;Austria;United Kingdom;Italy;Switzerland;France;Canada ...